|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocn124095086 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
070510s2006 ne a ob 101 0 eng d |
010 |
|
|
|z 2006938638
|
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d IDEBK
|d OCLCQ
|d OCLCO
|d OCLCF
|d NLGGC
|d YDXCP
|d OCLCQ
|d ADU
|d E7B
|d SFB
|d EBLCP
|d IOSPR
|d DKDLA
|d MHW
|d OCLCQ
|d N9V
|d D6H
|d AZK
|d OCLCQ
|d AGLDB
|d OCLCO
|d COCUF
|d TOA
|d OCLCO
|d OCLCQ
|d OCLCO
|d MOR
|d PIFBR
|d ZCU
|d OCLCQ
|d MERUC
|d OCLCQ
|d U3W
|d OCLCO
|d STF
|d WRM
|d VNS
|d OCLCO
|d VTS
|d OCLCO
|d ICG
|d VT2
|d AU@
|d OCLCQ
|d OCLCO
|d WYU
|d OCLCO
|d S9I
|d OCLCO
|d DKC
|d OCLCO
|d OCLCQ
|d M8D
|d OCLCA
|d CEF
|d UKCRE
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|d VLY
|d SDF
|d TUHNV
|
016 |
7 |
|
|a 101316462
|2 DNLM
|
019 |
|
|
|a 212941058
|a 243615875
|a 465672525
|a 475744259
|a 491261269
|a 614486372
|a 648166597
|a 744981633
|a 814477760
|a 955665607
|a 960883481
|a 961579243
|a 962618111
|a 966240328
|a 974149822
|a 974435414
|a 988508041
|a 992101844
|a 1018003753
|a 1029495536
|a 1037777101
|a 1038666462
|a 1041914203
|a 1055399811
|a 1064017946
|a 1065078671
|a 1081295498
|a 1086940857
|a 1096478524
|a 1153509276
|a 1162533735
|a 1200855461
|a 1228582123
|
020 |
|
|
|a 9781429467711
|q (electronic bk.)
|
020 |
|
|
|a 1429467711
|q (electronic bk.)
|
020 |
|
|
|a 1280810556
|
020 |
|
|
|a 9781280810558
|
020 |
|
|
|a 143370157X
|q (electronic bk. ;
|q Adobe Reader)
|
020 |
|
|
|a 9781433701573
|q (electronic bk. ;
|q Adobe Reader)
|
020 |
|
|
|a 9781607502180
|
020 |
|
|
|a 1607502186
|
020 |
|
|
|z 1586037021
|q (hardcover)
|
020 |
|
|
|z 9781586037024
|q (hardcover)
|
029 |
1 |
|
|a AU@
|b 000043833327
|
029 |
1 |
|
|a AU@
|b 000051417193
|
029 |
1 |
|
|a AU@
|b 000062627407
|
029 |
1 |
|
|a DEBBG
|b BV043101231
|
029 |
1 |
|
|a DEBBG
|b BV044122935
|
029 |
1 |
|
|a DEBSZ
|b 422216623
|
029 |
1 |
|
|a GBVCP
|b 802281605
|
029 |
1 |
|
|a NLGGC
|b 306367831
|
029 |
1 |
|
|a NLGGC
|b 38222454X
|
029 |
1 |
|
|a NLM
|b 101316462
|
029 |
1 |
|
|a NZ1
|b 14237291
|
035 |
|
|
|a (OCoLC)124095086
|z (OCoLC)212941058
|z (OCoLC)243615875
|z (OCoLC)465672525
|z (OCoLC)475744259
|z (OCoLC)491261269
|z (OCoLC)614486372
|z (OCoLC)648166597
|z (OCoLC)744981633
|z (OCoLC)814477760
|z (OCoLC)955665607
|z (OCoLC)960883481
|z (OCoLC)961579243
|z (OCoLC)962618111
|z (OCoLC)966240328
|z (OCoLC)974149822
|z (OCoLC)974435414
|z (OCoLC)988508041
|z (OCoLC)992101844
|z (OCoLC)1018003753
|z (OCoLC)1029495536
|z (OCoLC)1037777101
|z (OCoLC)1038666462
|z (OCoLC)1041914203
|z (OCoLC)1055399811
|z (OCoLC)1064017946
|z (OCoLC)1065078671
|z (OCoLC)1081295498
|z (OCoLC)1086940857
|z (OCoLC)1096478524
|z (OCoLC)1153509276
|z (OCoLC)1162533735
|z (OCoLC)1200855461
|z (OCoLC)1228582123
|
050 |
|
4 |
|a BF311
|b .T45 2006eb
|
060 |
|
4 |
|a 2007 L-331
|
060 |
|
4 |
|a WM 204
|b T443 2006
|
072 |
|
7 |
|a SCI
|x 090000
|2 bisacsh
|
072 |
|
7 |
|a PSY
|x 008000
|2 bisacsh
|
072 |
|
7 |
|a K
|2 bicssc
|
082 |
0 |
4 |
|a 153
|2 22
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Thinking about cognition: concepts, targets and therapeutics /
|c C.G. Kruse [and others] (eds.).
|
260 |
|
|
|a Amsterdam ;
|a Washington, DC :
|b IOS Press,
|c ©2006.
|
300 |
|
|
|a 1 online resource (ix, 133 pages) :
|b illustrations (some color)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a data file
|
490 |
1 |
|
|a Solvay Pharmaceuticals Conferences,
|x 1566-7685 ;
|v v. 5
|
500 |
|
|
|a International conference proceedings.
|
520 |
|
|
|a 100 Years after the discovery of Alzheimer's disease, neurological diseases and psychiatric disorders represent the largest and fastest growing unmet medical market with 2 billion affected people worldwide. Life expectancy of humans continues to increase, and the world population is aging. Advanced age may lead to deterioration of cognitive functions of the brain. There seems to be consensus that on the background of aging, several factors may render humans prone to dementia. Psychiatric and neurological isorders such as schizophrenia, bipolar disorder or Parkinson's disease may contribute to development of dementia. More people today are looking for help regarding their learning and memory capabilities. Although increasing knowledge on neuronal networks s transforming our view of the human brain and its function and we understand psychiatric and neurological diseases better today than ever before, novel therapies are needed to respond to the growing demand of patients for assistance with memory loss and earning impairment. In fact, it is expected that novel therapies aiming at the processing of amyloid, or at activation of glutamatergic or nicotinergic systems will demonstrate adequate efficacy in improving learning and memory disturbances. This publication stands as a comprehensive overview of the cellular and molecular mechanisms underlying the development of cognitive impairment. It integrates discoveries concerning dementia, such as mild cognitive impairment and Alzheimer's disease associated dementia vascular dementia, retardation syndromes, and psychiatric and neurological disorders related cognitive impairments. This book will be useful to physicians, biologists, and those pursuing an interest or concerned with memory impairment. 100 Years after te discovery of Alzheimer's disease, neurological diseases and psychiatric disorders represent the largest and fastest growing unmet medical market with 2 billion affected people worldwide. Life expectancy of humans continues to increase, and the world poplation is aging. Advanced age may lead to deterioration of cognitive functions of the brain. There seems to be consensus that on the background of aging, several factors may render humans prone to dementia. Psychiatric and neurological disorders such as shizophrenia, bipolar disorder or Parkinson's disease may contribute to development of dementia. More people today are looking for help regarding their learning and memory capabilities. Although increasing knowledge on neuronal networks is transforming ourview of the human brain and its function and we understand psychiatric and neurological diseases better today than ever before, novel therapies are needed to respond to the growing demand of patients for assistance with memory loss and learning impairment In fact, it is expected that novel therapies aiming at the processing of amyloid, or at activation of glutamatergic or nicotinergic systems will demonstrate adequate efficacy in improving learning and memory disturbances. This publication stands as a comrehensive overview of the cellular and molecular mechanisms underlying the development of cognitive impairment. It integrates discoveries concerning dementia, such as mild cognitive impairment and Alzheimer's disease associated dementia, vascular dementia retardation syndromes, and psychiatric and neurological disorders related cognitive impairments. This book will be useful to physicians, biologists, and those pursuing an interest or concerned with memory impairment.
|
588 |
0 |
|
|a Print version record.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Title page; Preface; List of Contributors; Contents; Conference Preface; Keynote Lecture -- The Meaning of Cognition in our Society and Health Care Systems; Age-Associated Memory Impairment; Cognition in Alzheimer's Disease and Related Disorders; Cognitive Deficits as a Core Feature of Schizophrenia; Cognition in Depression and Mania; Linking Pre-Clinical and Clinical Approaches to Therapy for Cognitive Dysfunction in Neuropsychiatric and Neurodegenerative Disorders; Pre-Clinical Models of Cognition: The Role of the Cannabis Subtype 1 Receptor.
|
546 |
|
|
|a English.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Cognition.
|
650 |
|
0 |
|a Cognition
|x Age factors.
|
650 |
|
0 |
|a Cognition
|x Effect of drugs on.
|
650 |
1 |
2 |
|a Cognition Disorders
|x physiopathology
|
650 |
2 |
2 |
|a Cognition Disorders
|x drug therapy
|
650 |
|
2 |
|a Cognition
|
650 |
|
6 |
|a Cognition.
|
650 |
|
6 |
|a Cognition
|x Facteurs liés à l'âge.
|
650 |
|
6 |
|a Cognition
|x Effets des médicaments sur.
|
650 |
|
7 |
|a cognition.
|2 aat
|
650 |
|
7 |
|a SCIENCE
|x Cognitive Science.
|2 bisacsh
|
650 |
|
7 |
|a PSYCHOLOGY
|x Cognitive Psychology.
|2 bisacsh
|
650 |
|
7 |
|a Cognition
|2 fast
|
650 |
|
7 |
|a Cognition
|x Age factors
|2 fast
|
650 |
|
7 |
|a Cognition
|x Effect of drugs on
|2 fast
|
655 |
|
2 |
|a Congress
|
655 |
|
7 |
|a proceedings (reports)
|2 aat
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congrès.
|2 rvmgf
|
758 |
|
|
|i has work:
|a Thinking about Cognition (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCXDFqtrKhgTppd9xhdbFfC
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|t Thinking about cognition.
|d Amsterdam ; Washington, DC : IOS Press, ©2006
|z 9781586037024
|w (DLC) 2006938638
|w (OCoLC)137305488
|
830 |
|
0 |
|a Solvay Pharmaceuticals Conferences ;
|v v. 5.
|x 1566-7685
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=287005
|z Texto completo
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL287005
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10167406
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 187951
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 81055
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2557734
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2625010
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3207234
|
994 |
|
|
|a 92
|b IZTAP
|